Maximilian Merz: Smells like team spirit
Maximilian Merz, University, shared a post on LinkedIn:
“Smells like team spirit*
I am super proud to see our work on single-cell multiomics in anti-BCMA CAR T-cells for relapsed/refractory multiple myeloma being published in Nature Cancer!
This was a great effort from a multi-disciplinary team of researchers from the Leipzig University, ICCAS – Innovation Center Computer Assisted Surgery and Fraunhofer IZI. Together with our friends from Singleron Biotechnologies we were able to demonstrate that patients who show sub-optimal response to anti-BCMA CAR T-cells can be identified at apheresis and show distinct changes in the CAR T and non-CAR T-cell compartment after infusion.
Special thanks to:
– our bioinformagicians Nora Grieb, Michael Rade and their supervisor Kristin Reiche
– my partner in crime, GMP wizard Vladan Vucinic
– Ulrike Köhl and Uwe Platzbecker for supporting this project from the very early beginnings
– International Myeloma Society and Paula and Rodger Riney Foundation, The Janssen Pharmaceutical Companies of Johnson and Johnson, SpringWorks Therapeutics, Deutsche Forschungsgemeinschaft (DFG) – German Research Foundation for the financial support!
This work built the foundation for our recently approved CERTAINTY EU HORIZON project. We will use our single-cell multiomic platform to build virtual twins for improved CAR T-cell manufacturing and application.
Stay tuned!
*yes, I grew up in the 90s”
Source: Maximilian Merz/LinkedIn
About OncoDaily
OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within short period of time it became one of the leading oncology media platforms globally.
OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.
The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023